NCT06590805

Brief Summary

The purpose of this study was to reveal the effect of electroacupoint on scanty milk production in lactating women.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2024

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

September 4, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

4 months

First QC Date

September 4, 2024

Last Update Submit

September 6, 2024

Conditions

Keywords

ElectroacupointPostnatal careDiminutive milk productionLactating woman

Outcome Measures

Primary Outcomes (3)

  • Change in Baby Weight.

    Measurement of Baby Weight using the Baby Weight Scale.

    Change from Baseline Baby Weight at three months.

  • Change in Serum Prolactin Level.

    Measurement of Serum Prolactin Level using the Serum Blood Test.

    Change from Baseline Serum Prolactin Level at three months.

  • Change in Flow of Milk.

    Measurement of Flow of Milk using the Visual Analogue Scale.

    Change from Baseline Flow of Milk at three months.

Study Arms (2)

Electroacupoint combined with postnatal care

EXPERIMENTAL

Electroacupoint stimulation using the Electroacupoint device and postnatal care diet in form of balanced diet and drinking sufficient clean water and routine postnatal care.

Procedure: Electrotherapy using Chattanooga stimulation unitDietary Supplement: Balanced Diet using domperidone drug, iron, and folic acid supplementation.

postnatal care only

ACTIVE COMPARATOR

Postnatal care diet in form of balanced diet and drinking sufficient clean water and routine postnatal care.

Dietary Supplement: Balanced Diet using domperidone drug, iron, and folic acid supplementation.

Interventions

Electroacupoint stimulation using the Chattanooga intellect transport 2-channel electrotherapy stimulation unit 2783. It uses the influences energy flows by needling the acupuncture points which lie along the body meridians to achieve a harmonious balance between physical, emotional, and spiritual states. The same effect can be achieved without the use of needles. These needleless stimulations are noninvasive and nontraumatic and are useful for individuals who are scared of needles. They are also associated with decreased risk of infection or bruise.

Electroacupoint combined with postnatal care

Postnatal care diet in form of balanced diet using domperidone drug, iron, and folic acid supplementation. Additionally, drinking sufficient clean water and routine postnatal care. It was performed by asking the participant to take ten mg domperidone three times a day after meals. Iron and folic acid supplementation were also continue for three months after birth.

Electroacupoint combined with postnatal carepostnatal care only

Eligibility Criteria

Age25 Years - 30 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThis study is specified for Females who have diminutive milk production.
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • They were complaining of insufficiency of lactation within the first month after cesarean section.
  • They are using mixed feeding; both breast and bottle feeding, between three and six bottles per day.
  • Their age ranged from 25-30 years old.
  • Their body mass index didn't exceeded 30 kg/m2.

You may not qualify if:

  • Postpartum haemorrhage.
  • Cardiorespiratory disease.
  • Diabetes mellitus.
  • Breast cancer.
  • Previous surgeries in the chest, breast, or the surrounding area.
  • Anemia.
  • Any causes that hindered their normal breastfeeding (retraced, cracked, inflamed, or inverted nipples).
  • Receiving contraceptive pills.
  • Having infants with conditions that may affect the lactation process such as congenital abnormalities of the mouth (tongue tie, cleft palate).
  • Congenital heart disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kafrelsheikh University

Kafrelsheikh, Egypt

RECRUITING

MeSH Terms

Interventions

Iron

Intervention Hierarchy (Ancestors)

Metals, HeavyElementsInorganic ChemicalsTransition ElementsMetals

Study Officials

  • Haytham I Morsi, M.Sc.

    Kafrelsheikh University

    STUDY DIRECTOR

Central Study Contacts

Sara E Seyam, B.Sc.

CONTACT

Haytham I Morsi, M.Sc.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two Parallel Groups for Comparison.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

September 4, 2024

First Posted

September 19, 2024

Study Start

September 1, 2024

Primary Completion

January 1, 2025

Study Completion

June 1, 2025

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations